📢📢 APTOS-ZOC AI Seminar (May 29, 2021) & APTOS 2021 Best Paper & Poster Awards


	View in browser

Adoption of AI in the Management of

Cataract, Retinal Diseases & Glaucoma

Session 1: 9:00 - 10:00 a.m.

Adoption of AI in Cataract Management

Uday DEVGAN

The future of IOL calculations is AI

Haotian LIN

AI for Anterior Segment Diseases

Xiaohang WU

AI for Cataract in Adult Population

Session 2: 10:00 - 11:00 a.m.

Translation from Algorithms to Products (Retinal Diseases)

Michael ABRAMOFF

Autonomous AI in Healthcare: From AI Concept to Product Reality

Carol CHEUNG

Using an AI-Based OCT Image Analysis for Diabetic Macular Edema Screening

Chao HE

Developing an NPMA-Approved Medical AI Product

Session 3: 11:00 - 12:00 noon

Adoption of AI in Glaucoma Management

Michael GIRARD

Describing the Structural Phenotype of the Glaucomatous Optic Nerve Head using Artificial Intelligence

Kai HUANG

High Precision Robots for Retinal Surgeries

Xiulan ZHANG

iGlaucoma: Towards Automated Assessment of Ocular Changes in Glaucoma

Best Paper & Best Poster Awards

Registration and abstract submission are now open. We have set up the Best Paper Award and the Best Poster Award for the first time. The Best Paper presenter will receive US$200 while the Best Poster presenter will receive US$100. Deadline for submission is Jun 30, 2021. Act now before it's too late.

Submit an abstract now

APTOS 2021 is a hybrid meeting where delegates can choose to join us in person or online. As our response to the pandemic and its aftermath, free registration is offered to all who are interested in attending the event on a first come first serve basis. Check out our preliminary program and see which session you are interested in.

APTOS 2021 Diamond Sponsor

Asia Pacific Tele-Ophthalmology Society

State Key Laboratory (Ophthalmology) Zhongshan Ophthalmic Center, Sun Yat-Sen University, 1/F, No. 7 Jinsui Road, Zhujiang New Town, Tianhe District, Guangzhou
China

You received this email because you signed up on our website or made a purchase from us.

Unsubscribe